Atossa Therapeutics (ATOS)
Develops oral (Z)-endoxifen for breast cancer and selected rare diseases.
$2.49
At close+0.07 (+2.89%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.92
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.05−$0.05−$0.07−$1.05−$1.19−$1.11−$0.95Pending
Estimate−$0.06−$0.06−$0.06−$1.05−$1.14−$1.22−$1.02−$0.92
Surprise+16.7%+16.7%−16.7%0.0%−4.6%+9.0%+6.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.92 | — | — |
| Aug 2026 | −$1.02 | −$0.95 | +6.9% |
| May 2026 | −$1.22 | −$1.11 | +9.0% |
| Mar 2026 | −$1.14 | −$1.19 | −4.6% |
| Nov 2025 | −$1.05 | −$1.05 | 0.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.92 | — | — | — | — | — | — |
| Aug 7, 2026 | −$1.02 | −$0.95 | +6.9% | — | — | — | −2.5% |
| May 8, 2026 | −$1.22 | −$1.11 | +9.0% | — | — | — | −1.8% |
| Mar 25, 2026 | −$1.14 | −$1.19 | −4.6% | — | — | — | −13.1% |
| Nov 12, 2025 | −$1.05 | −$1.05 | 0.0% | — | — | — | −1.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 14, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 26, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 28, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 8, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 12, 2016 | |||||||
| May 5, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 6, 2015 | |||||||